Cargando…
Correction to: Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355809/ https://www.ncbi.nlm.nih.gov/pubmed/35596941 http://dx.doi.org/10.1093/oncolo/oyac103 |
| _version_ | 1784763378995036160 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9355809 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93558092022-08-09 Correction to: Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma Oncologist Correction Notices Oxford University Press 2022-05-21 /pmc/articles/PMC9355809/ /pubmed/35596941 http://dx.doi.org/10.1093/oncolo/oyac103 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com. |
| spellingShingle | Correction Notices Correction to: Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma |
| title | Correction to: Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma |
| title_full | Correction to: Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma |
| title_fullStr | Correction to: Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma |
| title_full_unstemmed | Correction to: Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma |
| title_short | Correction to: Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma |
| title_sort | correction to: efficacy and safety of apatinib in patients with recurrent or refractory melanoma |
| topic | Correction Notices |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355809/ https://www.ncbi.nlm.nih.gov/pubmed/35596941 http://dx.doi.org/10.1093/oncolo/oyac103 |